Myotonic Dystrophy in Children

Introduction to Myotonic Dystrophy in Children

Myotonic Dystrophy (DM) is a multisystem disorder characterized by muscle weakness, myotonia, and involvement of various organs. There are two main types:

  • Myotonic Dystrophy Type 1 (DM1):
    • Also known as Steinert's disease
    • Most common form of muscular dystrophy in adults
    • Can present from birth to adulthood
  • Myotonic Dystrophy Type 2 (DM2):
    • Also known as proximal myotonic myopathy (PROMM)
    • Generally milder and rarely presents in childhood

Incidence: DM1 affects about 1 in 8,000 individuals worldwide

Inheritance: Autosomal dominant with anticipation (earlier onset and increased severity in subsequent generations)

Pathophysiology of Myotonic Dystrophy

Myotonic Dystrophy is caused by nucleotide repeat expansions affecting RNA processing:

  1. Genetic basis:
    • DM1: CTG repeat expansion in DMPK gene on chromosome 19q13.3
    • DM2: CCTG repeat expansion in CNBP gene on chromosome 3q21.3
  2. RNA toxicity:
    • Expanded repeats form RNA foci in nucleus
    • Sequestration of RNA-binding proteins (e.g., MBNL1, CUGBP1)
  3. Splicing dysregulation:
    • Altered splicing of multiple genes (e.g., CLCN1, INSR, TNNT2)
    • Leads to various tissue-specific symptoms
  4. Repeat instability:
    • Tendency for repeat expansion in successive generations
    • Explains anticipation phenomenon
  5. Multisystem effects:
    • Impacts skeletal and smooth muscle, heart, brain, endocrine system, and other organs

Clinical Presentation of Myotonic Dystrophy in Children

The presentation of Myotonic Dystrophy in children varies widely, with several distinct forms:

  1. Congenital Myotonic Dystrophy (most severe form):
    • Present at birth or in early infancy
    • Severe hypotonia and weakness
    • Respiratory distress often requiring ventilation
    • Feeding difficulties
    • Characteristic facial features (inverted V-shaped upper lip, tented upper lip)
    • Club feet and other contractures
    • Developmental delays
  2. Childhood-onset Myotonic Dystrophy:
    • Onset between 1-10 years of age
    • Myotonia (delayed muscle relaxation after contraction)
    • Progressive muscle weakness, especially facial and distal muscles
    • Speech and swallowing difficulties
    • Cognitive impairment and learning disabilities
    • Gastrointestinal problems (constipation, abdominal pain)
  3. Juvenile-onset Myotonic Dystrophy:
    • Onset in adolescence
    • Mild muscle weakness and myotonia
    • Cataracts
    • Cardiac conduction abnormalities
    • Endocrine dysfunction (e.g., insulin resistance)

Additional features in children with DM1:

  • Fatigue
  • Daytime sleepiness
  • Behavioral and psychiatric issues (ADHD, autism spectrum features)
  • Gastrointestinal motility problems
  • Increased risk of certain cancers

Diagnosis of Myotonic Dystrophy in Children

Diagnosis of Myotonic Dystrophy involves clinical assessment, genetic testing, and supportive investigations:

  1. Clinical evaluation:
    • Characteristic muscle weakness pattern
    • Presence of myotonia
    • Multisystem involvement
    • Family history (although congenital cases often have unaffected mothers)
  2. Genetic testing (gold standard):
    • PCR and Southern blot analysis for CTG repeat expansion in DMPK gene (DM1)
    • CCTG repeat expansion testing in CNBP gene if DM2 is suspected
  3. Supportive tests:
    • Electromyography (EMG): Characteristic myotonic discharges
    • Muscle biopsy: Not usually necessary, shows characteristic changes if performed
    • Serum creatine kinase (CK): Normal to mildly elevated
  4. Additional assessments:
    • Ophthalmological examination for cataracts
    • Cardiac evaluation (ECG, echocardiogram)
    • Pulmonary function tests
    • Endocrine evaluations (thyroid function, glucose tolerance)
    • Neuropsychological testing

Prenatal and preimplantation genetic testing: Available for at-risk pregnancies

Management of Myotonic Dystrophy in Children

Management of Myotonic Dystrophy in children requires a multidisciplinary approach:

  1. Neonatal and infant care (for congenital DM):
    • Respiratory support, often including mechanical ventilation
    • Feeding support (nasogastric tubes, gastrostomy)
    • Treatment of neonatal complications (e.g., clubfoot)
  2. Neuromuscular management:
    • Physical therapy to maintain strength and prevent contractures
    • Occupational therapy for adaptive devices and strategies
    • Speech therapy for articulation and swallowing difficulties
    • Orthotic devices as needed
  3. Myotonia management:
    • Medications like mexiletine or lamotrigine if myotonia is severe
  4. Cardiac care:
    • Regular ECG and echocardiogram
    • Management of arrhythmias and conduction defects
    • Consider pacemaker or ICD if indicated
  5. Respiratory management:
    • Regular pulmonary function tests
    • Non-invasive ventilation if needed
    • Management of recurrent infections
  6. Gastrointestinal care:
    • Dietary modifications for dysphagia
    • Treatment of constipation and motility issues
  7. Endocrine management:
    • Monitoring and treatment of thyroid dysfunction
    • Management of insulin resistance and diabetes
  8. Ophthalmological care:
    • Regular eye exams for cataract detection and management
  9. Cognitive and behavioral support:
    • Special education services
    • Neuropsychological interventions
    • Management of ADHD and other behavioral issues
  10. Pain management:
    • Address chronic pain associated with muscle weakness and myotonia
  11. Genetic counseling:
    • For family planning and management of at-risk relatives
  12. Emerging therapies:
    • Clinical trials of antisense oligonucleotides targeting toxic RNA
    • Gene therapy approaches in development

Prognosis of Myotonic Dystrophy in Children

The prognosis for children with Myotonic Dystrophy varies widely depending on the form and severity:

  • Congenital Myotonic Dystrophy:
    • High mortality rate in the neonatal period (up to 25%)
    • Survivors often have significant developmental delays and disability
    • Improved outcomes with advances in neonatal care
  • Childhood-onset Myotonic Dystrophy:
    • Generally slower progression than congenital form
    • Variable impact on lifespan and quality of life
    • Cognitive impairment can significantly affect educational and social outcomes
  • Juvenile-onset Myotonic Dystrophy:
    • Often milder course with longer life expectancy
    • Progressive muscle weakness and systemic complications in adulthood

Factors influencing prognosis:

  • Age of onset (earlier onset generally associated with more severe disease)
  • CTG repeat size (larger expansions correlate with more severe phenotype)
  • Presence and severity of cardiac and respiratory involvement
  • Access to comprehensive multidisciplinary care

Long-term considerations:

  • Progressive muscle weakness and disability
  • Increased risk of cardiac events
  • Respiratory complications as a major cause of morbidity and mortality
  • Impact of cognitive impairment on independence and quality of life

Note: With appropriate management, many individuals with childhood or juvenile-onset DM1 can have a good quality of life and participate in various activities, albeit with some limitations.



Myotonic Dystrophy in Children
  1. What are the two main types of Myotonic Dystrophy (DM) that can affect children?
    The two main types are Type 1 (DM1) and Type 2 (DM2), with DM1 being more common in children.
  2. What is the genetic cause of Myotonic Dystrophy Type 1?
    DM1 is caused by an expanded CTG trinucleotide repeat in the DMPK gene on chromosome 19.
  3. What is meant by the term "anticipation" in Myotonic Dystrophy?
    "Anticipation" refers to the earlier onset and increased severity of symptoms in successive generations due to expansion of the CTG repeat.
  4. What are the characteristics of congenital Myotonic Dystrophy?
    Congenital DM is characterized by severe hypotonia, respiratory distress, feeding difficulties, and facial weakness at birth.
  5. How does Myotonic Dystrophy affect a child's muscles?
    DM causes progressive muscle weakness and myotonia (delayed relaxation after muscle contraction).
  6. What cardiac issues can be associated with Myotonic Dystrophy in children?
    Cardiac issues can include conduction defects, arrhythmias, and rarely, cardiomyopathy.
  7. How does Myotonic Dystrophy affect a child's cognitive development?
    DM can cause varying degrees of cognitive impairment, learning disabilities, and behavioral issues.
  8. What endocrine problems can occur in children with Myotonic Dystrophy?
    Endocrine problems may include insulin resistance, hypothyroidism, and hypogonadism.
  9. How is Myotonic Dystrophy inherited?
    Myotonic Dystrophy is inherited in an autosomal dominant pattern.
  10. What is the gold standard for diagnosing Myotonic Dystrophy in children?
    The gold standard for diagnosis is genetic testing to detect the expanded CTG repeat in the DMPK gene.
  11. How does Myotonic Dystrophy affect a child's respiratory function?
    DM can cause respiratory muscle weakness, leading to sleep apnea, hypoventilation, and increased risk of respiratory infections.
  12. What gastrointestinal issues are common in children with Myotonic Dystrophy?
    Common GI issues include dysphagia, constipation, and in some cases, pseudo-obstruction.
  13. How does Myotonic Dystrophy affect a child's eyes?
    DM can cause cataracts, even in childhood, as well as ptosis (drooping eyelids) and extraocular muscle weakness.
  14. What is the typical lifespan for children diagnosed with Myotonic Dystrophy?
    Lifespan varies widely depending on disease severity, but congenital cases have a higher mortality rate in the first year of life.
  15. How does Myotonic Dystrophy affect a child's speech and language development?
    DM can cause speech and language delays due to cognitive impairment and weakness of speech muscles.
  16. What is the role of physical therapy in managing Myotonic Dystrophy in children?
    Physical therapy helps maintain muscle strength, improve mobility, and prevent contractures.
  17. How does Myotonic Dystrophy affect a child's growth and development?
    DM can cause growth delays and may affect pubertal development in some cases.
  18. What is the importance of regular cardiac monitoring in children with Myotonic Dystrophy?
    Regular cardiac monitoring is crucial to detect and manage conduction defects and arrhythmias, which can be life-threatening.
  19. How does Myotonic Dystrophy affect a child's ability to participate in sports and physical activities?
    Muscle weakness and myotonia can limit participation in some activities, but low-impact exercises are often beneficial and encouraged.
  20. What is the role of occupational therapy in managing Myotonic Dystrophy in children?
    Occupational therapy helps children adapt to muscle weakness, improve fine motor skills, and maintain independence in daily activities.
  21. How does Myotonic Dystrophy affect a child's sleep patterns?
    DM can cause sleep disturbances due to respiratory issues, sleep apnea, and difficulty changing positions during sleep.
  22. What is the significance of family history in diagnosing Myotonic Dystrophy in children?
    A family history of DM is significant due to its autosomal dominant inheritance, but de novo mutations can also occur.
  23. How does Myotonic Dystrophy affect a child's digestive system?
    DM can cause smooth muscle dysfunction leading to issues like gastroparesis, constipation, and gallbladder problems.
  24. What is the role of genetic counseling for families with a child diagnosed with Myotonic Dystrophy?
    Genetic counseling provides information about inheritance, recurrence risks, and family planning options, including prenatal testing.
  25. How does Myotonic Dystrophy affect a child's immune system?
    While DM doesn't directly affect the immune system, respiratory muscle weakness can increase susceptibility to respiratory infections.
  26. What is the importance of regular pulmonary function testing in children with Myotonic Dystrophy?
    Regular pulmonary function tests help monitor respiratory muscle strength and detect early signs of respiratory insufficiency.
  27. How does Myotonic Dystrophy affect a child's ability to swallow?
    DM can cause dysphagia (difficulty swallowing) due to weakness of the muscles involved in swallowing.
  28. What is the current status of gene therapy research for Myotonic Dystrophy in children?
    Gene therapy research is ongoing, focusing on targeting the toxic RNA that results from the expanded CTG repeat.
  29. How does Myotonic Dystrophy affect a child's skin?
    DM can cause various skin issues, including frontal balding, pilomatrixomas, and hyperhidrosis.
  30. What is the role of assistive devices in managing Myotonic Dystrophy in children?
    Assistive devices such as ankle-foot orthoses, wheelchairs, and adaptive utensils can help maintain function and independence.


Further Reading
Powered by Blogger.